AI-generated analysis. Always verify with the original filing.
AbbVie Inc. reported FY 2025 net revenues of $61.16 billion, generating operating earnings of $15.07 billion and net earnings attributable to AbbVie Inc. of $4.23 billion. The company's gross profit was $42.96 billion, resulting in a gross margin of 70.2%. Operating margin stood at 24.6%. Cash flow from operating activities was strong at $19.03 billion, while free cash flow was $17.82 billion. The balance sheet shows total assets of $133.96 billion, with significant long-term debt of $58.94 billion and a total equity deficit of -$3.23 billion. Basic and diluted earnings per share were $2.00. The company paid $11.66 billion in dividends and repurchased $980 million in treasury stock during the year.
EPS
$2.00
Revenue
$61.16B
Net Income
$4.23B
Gross Margin
70.2%
Gross Profit
$42.96B
free cash flow
$17.82B
Operating Income
$15.07B
operating margin
24.6%